138 related articles for article (PubMed ID: 22872536)
1. [Primary arterial hypertension: update 2012].
Hausberg M; Krämer BK
Dtsch Med Wochenschr; 2012 Aug; 137(31-32):1572-4. PubMed ID: 22872536
[No Abstract] [Full Text] [Related]
2. Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
Wong J; Molyneaux L; Constantino M; Twigg SM; Yue DK
Diabetes Obes Metab; 2010 Dec; 12(12):1072-8. PubMed ID: 20977578
[TBL] [Abstract][Full Text] [Related]
3. [Treatment for hypertension in patients with renal diseases].
Nakamura S
Nihon Rinsho; 2004 Mar; 62 Suppl 3():452-9. PubMed ID: 15179937
[No Abstract] [Full Text] [Related]
4. [Metformin should not be used by patients with reduced renal function].
Gudmundsdottir H; Brørs O; Os I
Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
[No Abstract] [Full Text] [Related]
5. [Hypertension and diabetic nephropathy, a dangerous duo].
Hausberg M; Hohage H; Kosch M
Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
[No Abstract] [Full Text] [Related]
6. In brief: aliskiren trial terminated.
Med Lett Drugs Ther; 2012 Jan; 54(1382):5. PubMed ID: 22267213
[No Abstract] [Full Text] [Related]
7. ACE inhibitors and ARBs: antihypertensive medications in CKD.
Szromba C
Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
[No Abstract] [Full Text] [Related]
8. [Intensified treatment of type 2 diabetes mellitus. Is polypharmacy necessary and justified?].
Pedersen OB; Gaede PH
Ugeskr Laeger; 2000 Jun; 162(25):3582-91. PubMed ID: 11016281
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice. Resistant or difficult-to-control hypertension.
Moser M; Setaro JF
N Engl J Med; 2006 Jul; 355(4):385-92. PubMed ID: 16870917
[No Abstract] [Full Text] [Related]
10. [Antihypertensive treatment in the type 2 diabetic].
Fournier A
Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
[No Abstract] [Full Text] [Related]
11. Non-responders.
Os I
Wien Med Wochenschr; 1995; 145(15-16):357-60. PubMed ID: 7502515
[TBL] [Abstract][Full Text] [Related]
12. Management of blood pressure in patients with diabetes.
Grossman E; Messerli FH
Am J Hypertens; 2011 Aug; 24(8):863-75. PubMed ID: 21525967
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertension in the elderly].
Hohage H; Gerhardt U; Suwelack BM
Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
[No Abstract] [Full Text] [Related]
15. Usefulness and safety of early blood pressure lowering after ischemic stroke still unproven.
Semplicini A
Am J Hypertens; 2007 Mar; 20(3):278. PubMed ID: 17324739
[No Abstract] [Full Text] [Related]
16. [Treatment of resistant hypertension].
Baumgart P
Med Klin (Munich); 2005 Apr; 100(4):200-6; quiz 207-8. PubMed ID: 15834529
[No Abstract] [Full Text] [Related]
17. Valsartan. Just a second-line antihypertensive drug.
Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
[TBL] [Abstract][Full Text] [Related]
18. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
Dominiak P
MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
[No Abstract] [Full Text] [Related]
19. [Renal side effects of angiotensin converting enzyme inhibitors].
Schmidt A; Mayer G
Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
[TBL] [Abstract][Full Text] [Related]
20. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
Zidek W
MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
